Using different types of assays, researchers found both cellular and humoral immune responses for up to eight months in coronavirus
Home » Severe Acute Respiratory Syndrome »
Purely mathematical perspective on delaying the second dose of the SARS-CoV-2 vaccine
The three most popularly administered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines developed so far (Pfizer, Oxford/AstraZeneca, and Moderna)